Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subsys for procedural burn pain
NCT02241486Phase 3Terminated
- Sponsor
- Loyola University Chicago
- Start
- Sep 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fentanyl (transdermal patch + oral transmucosal lozenge), sponsored by Loyola University Chicago. Primary endpoint: Pain Relief. Started Sep 2013; status: terminated.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
Beyond the preview
Go deeper on NCT02241486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02241486.